Injective (INJ) is currently trading at $3.80, experiencing a 24-hour change of 1.48%. The daily price range has been relatively tight, with a high of $3.81 and a low of $3.72, indicating moderate volatility as the price oscillates within a narrow band of 0.09%.

The trading volume stands at approximately 44.1 million, which represents 11.60% of the market cap, reflecting solid liquidity for INJ. The moving averages show positive momentum, with the 8, 13, and 21 SMAs all trending upward and demonstrating gains between 0.91% and 1.13%, while the longer-term 144 SMA shows a significant increase of 5.13%.

The 1-hour RSI is at 56, suggesting that the asset is neither overbought nor oversold, while the 7-day RSI is at 53, indicating a stable price action over the past week. Over the last 30 days, INJ has appreciated by 36.00%, which is a strong indication of bullish sentiment and robust performance over a longer time frame.

Given the current price of $3.80 is significantly lower than its all-time high of $52.62 achieved on March 14, 2024, there remains substantial upside potential. The positive price changes across different time frames, especially the 14-day increase of over 17%, support a bullish outlook moving forward.

Considering the overall trend, liquidity, and technical indicators, I recommend a Buy rating for Injective (INJ). The upward momentum in moving averages, coupled with a solid price performance in recent weeks, suggests that INJ is positioned for continued growth in the near term.